{
    "Trade/Device Name(s)": [
        "Wondfo Amphetamine Urine Test AMP 500 (Cup, DipCard)",
        "Wondfo Cocaine Urine Test COC 150 (Cup, DipCard)",
        "Wondfo Methamphetamine Urine Test MET 500 (Cup, DipCard)",
        "WONDFO Urine Test Amphetamine (Cup, DipCard)",
        "WONDFO Urine Test Cocaine (Cup, DipCard)",
        "WONDFO Urine Test Methamphetamine (Cup, DipCard)"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K161214",
    "Predicate Device Reference 510(k) Number(s)": [
        "K122809"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "DKZ",
        "DJC"
    ],
    "Summary Letter Date": "April 21, 2016",
    "Summary Letter Received Date": "April 29, 2016",
    "Submission Date": "June 8, 2016",
    "Regulation Number(s)": [
        "21 CFR 862.3250",
        "21 CFR 862.3100",
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Cocaine and cocaine metabolite test system",
        "Amphetamine test system",
        "Methamphetamine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamine",
        "Benzoylecgonine",
        "Methamphetamine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [
        "Cup",
        "DipCard",
        "Aluminum pouch with desiccant"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Competitive binding"
    ],
    "Methodologies": [
        "Immunochromatographic",
        "Lateral flow",
        "Antigen antibody immunochemistry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Test",
        "Cup",
        "DipCard"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo urine rapid immunochromatographic assays for qualitative detection of amphetamine, cocaine, and methamphetamine using cup and dipcard formats in urine specimens",
    "Indications for Use Summary": "OTC rapid qualitative urine tests for amphetamine (AMP 500), cocaine metabolite benzoylecgonine (COC 150), and methamphetamine (MET 500) at specified cutoffs, as preliminary screening devices with confirmatory GC/MS recommended",
    "fda_folder": "Toxicology"
}